USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Cash & Equivalents	151.34	181.77	330.42	288.42	239.83	311.92
Cash & Short-Term Investments	151.34	181.77	330.42	288.42	239.83	311.92
Cash Growth	-54.47%	-44.99%	14.56%	20.26%	-23.11%	32.83%
Other Receivables	-	8.22	7.2	7.21	7.16	7.42
Receivables	-	8.22	7.2	7.21	7.16	7.42
Inventory	83.27	69.74	61.45	67.09	98.32	90.22
Prepaid Expenses	27.26	13.76	11.39	11.38	13.85	8.68
Restricted Cash	-	-	-	-	-	0.96
Other Current Assets	-	5.7	7.28	10.28	5.95	6.08
Total Current Assets	261.87	279.19	417.75	384.38	365.12	425.29
Property, Plant & Equipment	96.53	111.12	107.68	111.69	120.07	117.33
Long-Term Investments	20	20	-	-	-	20
Goodwill	144.23	144.17	17.1	17.37	17.67	17.37
Other Intangible Assets	142.75	151.82	29.92	32.43	30.44	30.8
Long-Term Deferred Tax Assets	26.44	19.64	13.28	9.8	4.84	4.64
Other Long-Term Assets	42.72	22.25	47.03	40.88	39.6	25.47
Total Assets	734.53	748.19	632.76	596.55	577.74	640.89
Accounts Payable	17.9	11.98	10.07	11.05	13.51	18.2
Accrued Expenses	-	79.57	80.84	84.26	97.63	99.13
Short-Term Debt	-	23	0.79	-	-	-
Current Portion of Leases	-	6.01	7.28	6.89	7.08	8.62
Current Income Taxes Payable	-	3.71	3.3	4.97	5.19	7.76
Current Unearned Revenue	12.15	12.05	13.91	20.88	19.64	15.95
Other Current Liabilities	91.58	3.3	2.66	15.79	17.75	18.42
Total Current Liabilities	121.63	139.63	118.85	143.83	160.79	168.07
Long-Term Leases	-	10.19	5.14	7.68	10.22	12.86
Long-Term Deferred Tax Liabilities	4.66	4.07	4.55	4.07	7.5	12.01
Other Long-Term Liabilities	22.68	7.97	7.02	6.49	4.11	6.3
Total Liabilities	148.97	161.86	135.56	162.08	182.62	199.24
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	76.37	75.82	65.66	55.6	50.01	62.46
Retained Earnings	474.02	478.94	445.22	391.64	344.64	382.79
Comprehensive Income & Other	-19.35	-22.67	-13.7	-12.79	0.46	-3.63
Total Common Equity	531.06	532.11	497.2	434.47	395.12	441.65
Minority Interest	54.5	54.22	-	-	-	-
Shareholders' Equity	585.56	586.33	497.2	434.47	395.12	441.65
Total Liabilities & Equity	734.53	748.19	632.76	596.55	577.74	640.89
Total Debt	-	39.2	13.21	14.57	17.3	21.47
Net Cash (Debt)	151.34	142.56	317.22	273.85	222.54	290.45
Net Cash Growth	-54.47%	-55.06%	15.84%	23.06%	-23.38%	38.81%
Net Cash Per Share	7.99	7.44	16.40	14.18	10.94	13.66
Filing Date Shares Outstanding	18.27	18.9	19.24	19.29	19.32	20.85
Total Common Shares Outstanding	18.26	19.06	19.13	19.21	19.39	21.04
Working Capital	140.24	139.56	298.9	240.55	204.33	257.21
Book Value Per Share	29.08	27.91	25.99	22.62	20.37	20.99
Tangible Book Value	244.08	236.12	450.18	384.67	347.01	393.49
Tangible Book Value Per Share	13.37	12.39	23.53	20.03	17.89	18.70
Land	-	6.36	6.72	6.72	6.99	7.25
Buildings	-	76.68	77.8	78.07	80.82	79.67
Machinery	-	121.16	116.82	113.99	111.47	100.39
Leasehold Improvements	-	12.61	14.34	14.39	15.21	15.24

Updated Jul 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q